Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Free Report) have received an average recommendation of “Moderate Buy” from the five brokerages that are currently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1 […]